Company Registry

QT Holdings Corp (AKA:Quad Technologies)
Profile last edited on: 9/15/2017

Cell separation technologies
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3f Gill Street
Woburn, MA 01801
   (973) 216-4562
Multiple Locations:   
Congressional District:   05
County:   Middlesex

Public Profile

Founded to explore the potential of a unique dissolvable hydrogel technology invented at Northeastern University, Quad Technologies is disrupting cell separation and cell therapy workflows by providing cell biologists with a simple, cell-friendly capture and release technology for cell isolation. A primary focus is on developing best-in-class cell separation reagents for immuno-oncology and translational medicine applications. Promising areas of translational medical research today require scientists to isolate and grow pure, healthy cell populations from complex starting materials such as blood and tissue. Most current approaches used to isolate and purify cell populations are associated with low cell viability, low recovery efficiency and undesirable phenotypic changes due to retained magnetic labels on the cells, leftover from the cell separation process. Quad Technologies is improving existing cell separation tools by leveraging our novel QuickGel™ technology platform to provide drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Andrew J Ball -- Vice President of Research and Development

  Nithya J Jesuraj -- Research Scientist

  Sean Kevlahan -- Chief Executive Officer and Co-Founder

  Guokui Qin -- Research Director

SBIR firms in the news

There are no news available.